MedPath

Propoxyphene and Acetaminophen

PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN TABLETS, USP50 mg/325 mg and 100 mg/650 mg

Approved
Approval ID

2eb7266d-1d31-4cdc-96f5-987bb8373cc9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 28, 2010

Manufacturers
FDA

Altura Pharmaceuticals, Inc.

DUNS: 006890545

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

propoxyphene napsylate and acetaminophen

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63874-201
Application NumberANDA074843
Product Classification
M
Marketing Category
C73584
G
Generic Name
propoxyphene napsylate and acetaminophen
Product Specifications
Route of AdministrationORAL
Effective DateApril 28, 2010
FDA Product Classification

INGREDIENTS (11)

PROPOXYPHENE NAPSYLATEActive
Quantity: 100 mg in 1 1
Code: 38M219L1OJ
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
ACETAMINOPHENActive
Quantity: 650 mg in 1 1
Code: 362O9ITL9D
Classification: ACTIB
HYPROMELLOSEInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Propoxyphene and Acetaminophen - FDA Drug Approval Details